Market closedNon-fractional
Seer/SEER
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Seer
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
Ticker
SEER
Sector
Healthcare
Trading on
NASDAQ
Industry
Life Sciences Tools and Services
Headquarters
Redwood City, United States
Employees
147
Website
seer.bio
Seer Metrics
BasicAdvanced
$134M
Market cap
-
P/E ratio
-$1.29
EPS
1.52
Beta
-
Dividend rate
Price and volume
Market cap
$134M
Beta
1.52
Financial strength
Current ratio
25.265
Quick ratio
24.528
Long term debt to equity
6.623
Total debt to equity
7.218
Management effectiveness
Return on assets (TTM)
-14.14%
Return on equity (TTM)
-20.33%
Valuation
Price to revenue (TTM)
8.426
Price to book
0.35
Price to tangible book (TTM)
0.35
Price to free cash flow (TTM)
-2.272
Growth
Revenue change (TTM)
-3.45%
Earnings per share change (TTM)
-12.82%
3-year revenue growth (CAGR)
207.13%
3-year earnings per share growth (CAGR)
-8.40%
What the Analysts think about Seer
Analyst Ratings
Majority rating from 3 analysts.
Seer Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$3M
-31.82%
Net income
-$21M
16.38%
Profit margin
-686.66%
70.70%
Seer Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.37
-$0.33
-$0.28
-$0.32
-
Expected
-$0.40
-$0.40
-$0.37
-$0.30
-$0.36
Surprise
-6.33%
-17.50%
-24.32%
6.67%
-
Seer News
AllArticlesVideos
Seer to Report Second Quarter 2024 Financial Results on August 8, 2024
GlobeNewsWire·1 week ago
Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery
GlobeNewsWire·1 month ago
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ's Early Cancer Detection Study
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Seer stock?
Seer (SEER) has a market cap of $134M as of July 27, 2024.
What is the P/E ratio for Seer stock?
The price to earnings (P/E) ratio for Seer (SEER) stock is 0 as of July 27, 2024.
Does Seer stock pay dividends?
No, Seer (SEER) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Seer dividend payment date?
Seer (SEER) stock does not pay dividends to its shareholders.
What is the beta indicator for Seer?
Seer (SEER) has a beta rating of 1.52. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Seer stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.